Pear Therapeutics, Inc.

Thimble Point Acquisition Corp, trading under ticker THMA, is a healthcare-focused SPAC that completed its initial public offering in 2021 and was sponsored by Thimble Point Sponsor LLC, an entity affiliated with EW Healthcare Partners. The company filed this Form 8-K on June 15, 2022, during the pendency of its proposed business combination with Pear Therapeutics, Inc., a prescription digital therapeutics developer targeting behavioral health conditions including substance use disorder and insomnia. The de-SPAC transaction ultimately closed in December 2022, taking Pear Therapeutics public; the combined company subsequently filed for Chapter 11 bankruptcy protection in early 2023 and was delisted. Sign up at SpacDesk for the complete filing history, event timeline, and deal analytics on THMA and hundreds of other SPAC transactions.